Skip To Main Content
Natasha Daughtrey on Muck Rack

Natasha Daughtrey

As seen in: Law360, JD Supra, Mondaq, Goodwin, LexBlog, Life Science Leader, Law360 UK, Big Molecule Watch, Open Legal Blog Archive
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Natasha

Contact Natasha, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FDA Approves Shanghai Henlius Biotech IND for Cetuximab Biosimilar

|
By Natasha Daughtrey
| JD Supra
On May 10, 2026, Shanghai Henlius Biotech announced that the FDA has approved its IND for a proposed biosimilar, HLX05-N, to Eli Lilly’s ERBITUX (cetuximab) product for the treatment of metastatic colorectal cancer (mCRC). ERBITUX is approved in the United States for the treatment of KRAS wild-type, epidermal growth factor receptor (EGFR)-expressing mCRC, among other indications.
Open in Who Shared Issue with article?

FDA Approves Shanghai Henlius Biotech IND for Cetuximab Biosimilar

|
By Natasha Daughtrey
| Big Molecule Watch
On May 10, 2026, Shanghai Henlius Biotech announced that the FDA has approved its IND for a proposed biosimilar, HLX05-N, to Eli Lilly’s ERBITUX (cetuximab) product for the treatment of metastatic colorectal cancer (mCRC). ERBITUX is approved in the United States for the treatment of KRAS wild-type, epidermal growth factor receptor (EGFR)-expressing mCRC, among other indications.
Open in Who Shared Issue with article?

Update: Janssen Files BPCIA Complaint Against Bio-Thera And Accord Related To Golimumab Biosimilar

|
By Natasha Daughtrey, Christopher Cassella
| Mondaq
Natasha E. Daughtrey’s articles from Goodwin Procter LLP are most popular: with readers working within the Aerospace & Defence, Banking & Credit and Healthcare industries Goodwin Procter LLP are most popular: within Cannabis & Hemp, Criminal Law and Immigration topic(s) As we reported last week, Janssen Biotech, Inc. and Janssen Sciences Ireland UC (collectively, “Janssen”) filed under seal a BPCIA complaint in the U.S. District Court for the District of Delaware against Accord BioPharma, Inc.
Open in Who Shared View Duplicates (5) Issue with article?
See all 45 licensed articles (46 Total)